Abstract C215: EZN‐2208, a novel pegylated SN‐38 drug conjugate, markedly inhibits tumor growth and metastatic spreading in preclinical models of human neuroblastoma

2009 ◽  
Author(s):  
Fabio Pastorino ◽  
Monica Loi ◽  
Pamela Becherini ◽  
Michele Cilli ◽  
Laura Emionite ◽  
...  
Keyword(s):  
Tumor Growth ◽  
Preclinical Models ◽  
Human Neuroblastoma ◽  
Drug Conjugate ◽  
Metastatic Spreading

scholarly journals Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models

2019 ◽  
Vol 18 (7) ◽  
pp. 1195-1204 ◽  
Author(s):  
Mehran Makvandi ◽  
Hwan Lee ◽  
Laura N. Puentes ◽  
Sean W. Reilly ◽  
Komal S. Rathi ◽  
...  
Keyword(s):  
Alpha Particles ◽  
Preclinical Models ◽  
Human Neuroblastoma ◽  
Parp 1

Dexamethasone inhibits pancreatic tumor growth in preclinical models: Involvement of activating glucocorticoid receptor

2020 ◽  
Vol 401 ◽  
pp. 115118
Author(s):  
Ye Yao ◽  
Qing-yu Yao ◽  
Jun-sheng Xue ◽  
Xiu-yun Tian ◽  
Qi-ming An ◽  
...  
Keyword(s):  
Glucocorticoid Receptor ◽  
Tumor Growth ◽  
Pancreatic Tumor ◽  
Preclinical Models

scholarly journals In Vivo Bioluminescence Tomography for Monitoring Breast Tumor Growth and Metastatic Spreading: Comparative Study and Mathematical Modeling

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Séverine Mollard ◽  
Raphaelle Fanciullino ◽  
Sarah Giacometti ◽  
Cindy Serdjebi ◽  
Sebastien Benzekry ◽  
...  
Keyword(s):  
Mathematical Modeling ◽  
Tumor Growth ◽  
Comparative Study ◽  
Breast Tumor ◽  
Bioluminescence Tomography ◽  
Metastatic Spreading
Sign in / Sign up

Export Citation Format

Share Document